Celanese (CE)
(Delayed Data from NYSE)
$132.56 USD
+4.83 (3.78%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $132.52 -0.04 (-0.03%) 7:58 PM ET
5-Strong Sell of 5 5
B Value C Growth F Momentum C VGM
Brokerage Reports
Celanese Corporation [CE]
Reports for Purchase
Showing records 61 - 80 ( 477 total )
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
4Q22 First Look - with Light 1Q, Reduced ''23 Guide Still Too High, We Believe
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
2023 Themes, 4Q22 Preview - Trough Is Likely In, but 2023 Is Still a Very Tough Year
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
3Q22 Follow-Up - 4Q May Be Trough, but Recovery Could Be Slow
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
3Q22 First Look - Bull Case Gets More Complicated; 4Q Guide and M&M Below Expectations
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
Chemicals: 3Q22 Preview - Estimates Could Sink to Trough Levels by Year-End
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Company: Celanese Corporation
Industry: Chemical - Diversified
M&M EBITDA Flat Q/Q in 2Q May Not Be as Bad as Feared; Still Light vs. Target
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Celanese Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department